Home  >  Products  >  TBC1D4 (TBC1 domain family, member 4 ) Blocking Peptide (the C terminal of TBC1D4)(100ug)
TBC1D4 (TBC1 domain family, member 4 ) Blocking Peptide (the C terminal of TBC1D4)(100ug)

TBC1D4 (TBC1 domain family, member 4 ) Blocking Peptide (the C terminal of TBC1D4)(100ug)


Supplier: Aviva Systems Biology Incorporated
Star_fadedStar_fadedStar_fadedStar_fadedStar_faded
0 reviews | Write a Review Pencil
This is a synthetic peptide designed for use in combination with anti-TBC1D4 Antibody (ARP63880_P050), made by Aviva Systems Biology. It may block above mentioned antibody from binding to its target protein in western blot and/or immunohistochecmistry under proper experimental settings. There is no guarantee for its use in other applications. Please inquire for more details.
Reactivities: Human
Presku: AAP63880
Size: 100ug
Weight: 146kDa
Gene: 9882
Format: Lyophilized powder
Target: TBC1D4 may act as a GTPase-activating protein for RAB2A, RAB8A, RAB10 and RAB14. Isoform 2 promotes insulin-induced glucose transporter SLC2A4/GLUT4 translocation at the plasma membrane, thus increasing glucose uptake.
Alternative names: AS160; DKFZp779C0666